Chemist With A Conscience

Matthew Meselson is catalyzed whenever he sees ‘misguided’ national policies CAMBRIDGE, MASS--At age 19, future Harvard biochemist and noted activist Matthew Meselson dropped out of college, went to live in Paris, and pondered forging a career as a Freudian analyst ot na- tions. With youthful hubris, he thought he might be able to explain the genesis of wars and other avoidable human catastrophes by scrutinizing the actions of governments past and present through the prism of mode

Written byKaren Klinger
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Matthew Meselson is catalyzed whenever he sees ‘misguided’ national policies

CAMBRIDGE, MASS--At age 19, future Harvard biochemist and noted activist Matthew Meselson dropped out of college, went to live in Paris, and pondered forging a career as a Freudian analyst ot na- tions. With youthful hubris, he thought he might be able to explain the genesis of wars and other avoidable human catastrophes by scrutinizing the actions of governments past and present through the prism of modern psychiatry.

When he resumed what was to become a peripatetic path through higher education a year later, Meselson chose chemistry over psychiatry. He had decided, he says, that it is easier to "establish truth in chemistry than [in] psychiatry." But he remained convinced that all governments, the United States notably included, display certain kinds of perverse behavior that are predictable, given the foibles of human nature. As an example, he says: "It occurred ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies